12 Month Price Forecast For PDCO
Distance to PDCO Price Forecasts
PDCO Price Momentum
๐ค Considering Patterson (PDCO)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 11, 2025 12:44 PM UTC
PDCO Analyst Ratings & Price Targets
Based on our analysis of 14 Wall Street analysts, PDCO has a neutral consensus with a median price target of $31.35 (ranging from $24.00 to $31.35). Currently trading at $31.01, the median forecast implies a 1.1% upside. This outlook is supported by 0 Buy, 11 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Erin Wright at Morgan Stanley, projecting a 1.1% upside. Conversely, the most conservative target is provided by Jason Bednar at Piper Sandler, suggesting a 22.6% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PDCO Analyst Consensus
PDCO Price Target Range
Latest PDCO Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PDCO.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Dec 17, 2024 | Morgan Stanley | Erin Wright | Equal-Weight | Maintains | $31.35 |
Dec 12, 2024 | Baird | Jeff Johnson | Neutral | Maintains | $31.00 |
Dec 11, 2024 | Leerink Partners | Michael Cherny | Market Perform | Downgrade | $31.35 |
Dec 6, 2024 | Baird | Jeff Johnson | Neutral | Maintains | $25.00 |
Dec 6, 2024 | Piper Sandler | Jason Bednar | Neutral | Maintains | $24.00 |
Dec 5, 2024 | Stifel | Jonathan Block | Hold | Maintains | $24.00 |
Oct 8, 2024 | Evercore ISI Group | Ross Muken | In-Line | Maintains | $22.00 |
Sep 5, 2024 | UBS | Michael Cherny | Neutral | Maintains | $24.00 |
Sep 4, 2024 | Baird | Neutral | Maintains | $0.00 | |
Sep 4, 2024 | B of A Securities | Buy | Maintains | $0.00 | |
Aug 29, 2024 | B of A Securities | Michael Cherny | Buy | Maintains | $29.00 |
Aug 29, 2024 | Piper Sandler | Neutral | Maintains | $0.00 | |
Aug 29, 2024 | Morgan Stanley | Equal-Weight | Maintains | $0.00 | |
Aug 29, 2024 | Baird | Jeff Johnson | Neutral | Maintains | $28.00 |
Aug 29, 2024 | JP Morgan | Michael Minchak | Neutral | Maintains | $26.00 |
Aug 29, 2024 | Evercore ISI Group | Ross Muken | In-Line | Maintains | $23.00 |
Jul 9, 2024 | Evercore ISI Group | Ross Muken | In-Line | Maintains | $25.00 |
Jun 20, 2024 | JP Morgan | Michael Minchak | Neutral | Maintains | $29.00 |
Jun 20, 2024 | Morgan Stanley | Erin Wright | Equal-Weight | Maintains | $28.00 |
May 20, 2024 | B of A Securities | Michael Cherny | Buy | Maintains | $32.00 |
Stocks Similar to Patterson Cos Inc
The following stocks are similar to Patterson based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Patterson Cos Inc (PDCO) Financial Data
Patterson Cos Inc has a market capitalization of $2.74B with a P/E ratio of 18.3x. The company generates $6.53B in trailing twelve-month revenue with a 2.6% profit margin.
Revenue growth is -2.2% quarter-over-quarter, while maintaining an operating margin of +2.1% and return on equity of +16.3%.
Valuation Metrics
Growth & Margins
Financial Health
๐ฅ Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.

Patterson Cos Inc (PDCO) Company Overview
About Patterson Cos Inc
Distributes dental and animal health products.
The company operates through three segments: Dental, Animal Health, and Corporate. It generates revenue primarily through the sale of consumable products, dental equipment, and animal health supplies, alongside offering value-added services like practice management software and customer financing.
Patterson Companies has a diverse client base, including dentists, laboratories, and veterinarians, and operates across the U.S., U.K., and Canada. Founded in 1877 and headquartered in Saint Paul, Minnesota, it has a long-standing presence in the healthcare industry.
Company Information
Sector
Healthcare
Industry
Medical Distribution
Employees
7,600
CEO
Mr. Donald J. Zurbay
Country
United States
IPO Year
1992
Website
www.pattersoncompanies.comPatterson Cos Inc (PDCO) Latest News & Analysis
Patterson Companies, Inc. announced the expiration of its 40-day "go-shop" period. Patient Square Capital will acquire Patterson for $31.35 per share, valuing the deal at $4.1 billion.
The expiration of the go-shop period signals that Patterson's merger with Patient Square is likely to proceed, impacting share prices and investor confidence in the company's future.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP and PDCO on Behalf of Shareholders
1 month agoHalper Sadeh LLC is investigating several companies for potential federal securities law violations and breaches of fiduciary duties to shareholders.
Investigations by law firms into potential securities violations can signal risks for affected companies, potentially impacting stock prices and investor confidence.
Patterson has agreed to be acquired by Patient Square Capital for approximately $4.1 billion.
Patterson's acquisition at $4.1 billion indicates strong market interest and potential growth, which could affect stock prices and investor sentiment in the health sector.
Patterson Launches On $4.1 Billion Takeover. Can It Reinvigorate The Beleaguered Dental Space?
2 months agoPatterson Companies' stock surged following the announcement of a $4.1 billion takeover deal by Patient Square.
The $4.1 billion takeover by Patient Square indicates strong confidence in Patterson's future, potentially driving stock value and market interest.
Shareholders will receive $31.35 in cash per share as part of the deal.
The cash payout of $31.35 per share indicates a return on investment for shareholders, reflecting the company's valuation and potential for future growth or stability.
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Patterson Companies, Inc. - PDCO
2 months agoMonteverde & Associates is investigating Patterson Companies, Inc. (NASDAQ: PDCO) regarding its proposed merger with Patient Square Capital, following its success in shareholder recoveries.
The investigation into Patterson Companies' merger could impact its stock price, signaling potential risks or opportunities for investors in the company.
Frequently Asked Questions About PDCO Stock
What is Patterson Cos Inc's (PDCO) stock forecast for 2025?
Based on our analysis of 14 Wall Street analysts, Patterson Cos Inc (PDCO) has a median price target of $31.35. The highest price target is $31.35 and the lowest is $24.00.
Is PDCO stock a good investment in 2025?
According to current analyst ratings, PDCO has 0 Buy ratings, 11 Hold ratings, and 0 Sell ratings. The stock is currently trading at $31.01. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for PDCO stock?
Wall Street analysts predict PDCO stock could reach $31.35 in the next 12 months. This represents a 1.1% increase from the current price of $31.01. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Patterson Cos Inc's business model?
The company operates through three segments: Dental, Animal Health, and Corporate. It generates revenue primarily through the sale of consumable products, dental equipment, and animal health supplies, alongside offering value-added services like practice management software and customer financing.
What is the highest forecasted price for PDCO Patterson Cos Inc?
The highest price target for PDCO is $31.35 from Erin Wright at Morgan Stanley, which represents a 1.1% increase from the current price of $31.01.
What is the lowest forecasted price for PDCO Patterson Cos Inc?
The lowest price target for PDCO is $24.00 from Jason Bednar at Piper Sandler, which represents a -22.6% decrease from the current price of $31.01.
What is the overall PDCO consensus from analysts for Patterson Cos Inc?
The overall analyst consensus for PDCO is neutral. Out of 14 Wall Street analysts, 0 rate it as Buy, 11 as Hold, and 0 as Sell, with a median price target of $31.35.
How accurate are PDCO stock price projections?
Stock price projections, including those for Patterson Cos Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.